Best Practices and Lessons Learned from Cerevel Therapeutics Implementation of the elluminate® Clinical Data Platform
Recorded Live: May 12, 2021
As the variety, velocity and volume of clinical data has increased in recent years, so has the need for designing an optimized clinical data architecture that takes full advantage of modern data streams and analytics. In this webinar, learn how Cerevel Therapeutics rapidly created a clinical data ecosystem to support a portfolio of new therapies across various stages of clinical development in less than a year.
Richard Gleeson, Head of Clinical and R&D at Cerevel Therapeutics will discuss the business priorities that drove the clinical digital data architecture design along with stakeholder requirements and the resulting technology platforms selected. Best practices and lessons learned thus far in developing a modern clinical data architecture that supports flexible operating models, the needs of today’s trials and those in a post COVID world will also be shared.
Who Should Attend
This webinar is intended for clinical development leaders involved in:
- R&D IT
- Clinical Informatics
- Data Management
- Data Sciences
- Clinical Operations
- Digital Transformation
Senior Director, Data Strategies, eClinical Solutions
Dawn Kaminksi has over 20 years of experience in the pharmaceutical industry. She has worked in every level of clinical data management, from data coordinator to director, where she has participated in or had oversight for more than 250 clinical trials across various therapeutic areas. During her time in the industry, she has provided consultation to organizations on clinical trial conduct, best practices in data management and data capture as well as developed standardized libraries and templates to support the adoption of CDISC standards. She is an active member of SCDM as a GCDMP SME, course designer and webinar presenter. She serves as a member of the CDISC-CDASH core team, Diabetes TAUG team and CDASH CFAST Expanded Leadership Team.
Head of Clinical and R&D Technology, Cerevel Therapeutics
In his present position with Cerevel Therapeutics, Mr. Gleeson has the opportunity to head critical R&D technology initiatives to support the treatment of people living with neurological and neuropsychiatric disorders. He has previous experience as the Chief Technology Officer at Cogstate, a cognitive science company that commercializes rapid, reliable and highly sensitive computerized cognitive tests and neurological assessments. He also held various leadership positions within Parexel, notably as the Vice President, North America Operations, Platform Solutions, in which he led the pre-sales, deployment, and execution of Parexel’s SaaS eClinical Software and Solutions.